1. Medtech Insight

More Patients Free From Atrial Fibrillation With AI-Guided Pulmonary Vein Isolation Treatment

18% More Patients Free From AF With AI Guided Treatment Compared To PVI-Alone

 
• By Natasha Barrow

Volta Medical’s TAILORED-AF clinical trial demonstrates that AI can achieve "superior efficacy" in interventional cardiology. The study examined the use of AI-driven Volta AF-Xplorer in addition to pulmonary vein isolation in treating patient with persistent atrial fibrillation.

Volta Medical’s AI guided Pulmonary Vein Isolation tool, Volta AF-Xplorer.
Volta Medical’s AI guided Pulmonary Vein Isolation tool, Volta AF-Xplorer.

More patients are free from persistent atrial fibrillation (AF) when treated with AI-guided pulmonary vein isolation (PVI) compared to PVI alone, says Volta Medical’s “landmark” TAILORED-AF clinical trial published in Nature Medicine on the 14 February.

Over 12 months, 187 patients received AI-guided PVI, and 183 patients received conventional PVI -only treatment. In the tailored AI-guided PVI cohort, 88% of patients experienced freedom from AF after...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from Market Intelligence